Schizophrenia is a severe mental disorder characterized by cognitive, behavioral, and emotional dysfunctions. It involves positive symptoms like hallucinations and negative symptoms such as social withdrawal. The text delves into the Dopamine Hypothesis, the role of glutamate and serotonin, neuroanatomical alterations, disrupted brain connectivity, and the origins of these brain abnormalities, considering both genetic and environmental factors.
Show More
Schizophrenia is a chronic and severe mental disorder that affects cognitive, behavioral, and emotional functions
Positive symptoms
Positive symptoms include hallucinations and delusions
Negative symptoms
Negative symptoms include blunted affect and social withdrawal
Research has uncovered abnormalities in brain structure and function, particularly in the prefrontal cortex and medial temporal lobes
The Dopamine Hypothesis proposes that hyperactivity of dopamine transmission contributes to the positive symptoms of schizophrenia
The efficacy of antipsychotic drugs that block dopamine D2 receptors supports the Dopamine Hypothesis
The Dopamine Hypothesis has evolved to consider the role of dopamine in other brain regions and its interaction with other neurotransmitter systems
The Glutamate Hypothesis suggests that hypofunction of glutamatergic neurotransmission, particularly involving the NMDA receptor, may underlie the negative and cognitive symptoms of schizophrenia
Glutamate is the primary excitatory neurotransmitter in the brain and is essential for synaptic plasticity, learning, and memory
Deficits in glutamatergic signaling, especially in the prefrontal cortex, are thought to contribute to the cognitive impairments and diminished emotional and social engagement in schizophrenia
Serotonin, a neurotransmitter implicated in mood regulation, appears to be involved in the diverse symptomatology of schizophrenia
While antipsychotic medications primarily target dopamine receptors, many also affect serotonin receptors, potentially addressing a broader range of symptoms
The relationship between serotonin and schizophrenia is complex, with ongoing research needed to fully understand its role